DFD-03 (tazarotene) lotion, 0.1%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DFD-03 (tazarotene) lotion, 0.1%, covering 2020-08-17 to 2020-08-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris [Phase 2]